naphazoline has been researched along with Lacrimal Duct Obstruction in 2 studies
Naphazoline: An adrenergic vasoconstrictor agent used as a decongestant.
Lacrimal Duct Obstruction: Interference with the secretion of tears by the lacrimal glands. Obstruction of the LACRIMAL SAC or NASOLACRIMAL DUCT causing acute or chronic inflammation of the lacrimal sac (DACRYOCYSTITIS). It is caused also in infants by failure of the nasolacrimal duct to open into the inferior meatus and occurs about the third week of life. In adults occlusion may occur spontaneously or after injury or nasal disease. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p250)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
NEMETH, B | 1 |
MARTON, D | 1 |
TOTH, P | 1 |
KUGLER, S | 1 |
Lisch, K | 1 |
2 other studies available for naphazoline and Lacrimal Duct Obstruction
Article | Year |
---|---|
[APROPOS OF THE CONSERVATIVE TREATMENT OF LACRIMAL DUCT DISEASES].
Topics: Chlortetracycline; Cortisone; Drug Therapy; Eyelids; Fluoresceins; Humans; Lacrimal Apparatus; Lacri | 1964 |
[Conjunctival alterations by sympathomimetic drugs (author's transl)].
Topics: Aged; Conjunctiva; Eyelid Diseases; Female; Humans; Imidazoles; Lacrimal Duct Obstruction; Male; Mid | 1978 |